SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Pharmacy Practice
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Laven, D. L.
Right arrow Articles by Shaw, S. M.
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Detection of Drug Interactions Involving Radiopharmaceuticals: A Professional Responsibility of the Clinical Pharmacist

David L. Laven

Nuclear Pharmacy, PO Box 636, VA Medical Center, Bay Pines, FL 33504-0636

Stanley M. Shaw

Nuclear Pharmacy, PO Box 636, VA Medical Center, Bay Pines, FL 33504-0636

Radiopharmaceuticals are radioactive drugs used in nuclear medicine for diagnosis and, to some degree, for the treatment of disease. Considerable evidence exists in regard to the potential for altered biorouting of radiopharmaceuticals resulting from the coadministration of therapeutic drugs, as well as from certain disease states, nutritional conditions, and other factors. Altered biorouting may reduce the usefulness of the diagnostic test or provide misleading information. While retrospective identification of an altered biodistribution problem can be helpful, prospective detection is more desirable and can be achieved by a hospital-based pharmacist. Although most drug-radiopharmaceutical interactions are not beneficial, some nuclear medicine procedures are conducted using drug intervention to enhance the diagnostic efficacy of the test. Also, nuclear medicine procedures may be used to monitor the outcome of a therapeutic regimen or to aid in determining the pharmacologic effect of an investigation drug. While not covering the full scope of the area, the material in this chapter is intended to provide an introduction to the problems and opportunities associated with drug-radiopharmaceutical interactions and to stimulate pharmacists to provide clinical pharmacy services to nuclear medicine.

Journal of Pharmacy Practice, Vol. 2, No. 5, 287-298 (1989)
DOI: 10.1177/089719008900200506


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




Advertisement